Two Sigma Securities’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Two Sigma Securities’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,591	Closed	-$12K	–	3201
2018 Q2	$12K	Buy	+2,591	New	+$11.8K	﹤0.01%	2581
2017 Q4	–	Sell	-1,560	Closed	-$15K	–	2129
2017 Q3	$15K	Buy	1,560 +233	+18%	+$3.32K	﹤0.01%	852
2017 Q2	$28K	Buy	+1,327	New	+$27.8K	0.01%	764

Other funds holding IPCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Two Sigma Securities's IPCI Position: Q3 2018 in Review

Two Sigma Securities sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 2,591 shares — an estimated $12K sold.

Two Sigma Securities first reported a position in IPCI in Q2 2017 and held it in 3 quarters. The position peaked at $28K in Q2 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

Two Sigma Securities reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
Two Sigma Securities sold 2,591 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $12K.
Two Sigma Securities first reported a position in Intellipharmaceuticals International Inc. in Q2 2017 and held it in 3 quarters.
Two Sigma Securities's Intellipharmaceuticals International Inc. position peaked at $28K in Q2 2017.
10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Two Sigma Securities's 13F filing for Q3 2018, filed 14 Nov 2018.